# Specialised - Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema

> Pre-procurement notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS ENGLAND](/buyers/nhs-england/contract-awards)
- Tender value: £15,000,000
- Published: 26 January 2018
- Planned start: 1 July 2018
- Planned end: 30 June 2019
- Stage: pre_procurement
- Notice ID: dd289ab5-7b3b-4468-8bc0-a21550b99c9b-193943
- OCID: ocds-b5fd17-f6ad017f-eabb-4459-b2f1-537b3d8de17b

## Description

Hereditary Angioedema

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/dd289ab5-7b3b-4468-8bc0-a21550b99c9b-193943)